Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer10 Apr ETF APRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Buy
37,574
+25,507
+211% +$1.07M ﹤0.01% 1780
2025
Q4
$502K Sell
12,067
-2,581
-18% -$106K ﹤0.01% 2714
2025
Q3
$596K Sell
14,648
-460
-3% -$18.4K ﹤0.01% 2507
2025
Q2
$593K Buy
15,108
+9,463
+168% +$354K ﹤0.01% 2390
2025
Q1
$209K Hold
5,645
﹤0.01% 3171
2024
Q4
$218K Hold
5,645
﹤0.01% 3118
2024
Q3
$213K Buy
5,645
+59
+1% +$2.16K ﹤0.01% 3098
2024
Q2
$202K Buy
+5,586
New +$196K ﹤0.01% 3024

Other funds holding APRT

Cambridge Investment Research Advisors's APRT Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its AllianzIM U.S. Equity Buffer10 Apr ETF (APRT) stake by 211% in Q1 2026, buying an estimated $1.07M and bringing the position to 37,574 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Cambridge Investment Research Advisors first reported a position in APRT in Q2 2024 and has held it in 8 quarters since. 30 funds tracked by Wall St. Rank hold APRT as of Q1 2026.

  • Cambridge Investment Research Advisors held 37,574 shares of AllianzIM U.S. Equity Buffer10 Apr ETF worth $1.6M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 25,507 AllianzIM U.S. Equity Buffer10 Apr ETF shares in Q1 2026, an estimated $1.07M.
  • AllianzIM U.S. Equity Buffer10 Apr ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1780 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer10 Apr ETF in Q2 2024 and has held it in 8 quarters since.
  • 30 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Apr ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.